XCE Tirzepatide is a high-purity peptide compound designed for research applications. This pharmaceutical grade material acts as a triple agonist targeting the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R).
The XCE Tirzepatide formulation demonstrates significant potential in metabolic research applications. When administered through subcutaneous injection, this compound has shown to improve glucose tolerance in test models through activation of GIP or GLP-1 receptors.
Our XCE Tirzepatide is supplied as a white lyophilized powder in sterile vials with rubber stoppers. Each batch undergoes rigorous quality control testing to ensure consistency and purity standards are met for research purposes.
For research use only. Not for human consumption. This product is intended solely for laboratory research purposes by qualified professionals.